Increased expression of IL-21 reduces tumor growth by modulating the status of tumor-infiltrated lymphocytes

Chia Ling Hsieh, Shu Ching Hsu, Chia Rui Shen, Mei Yu Chen, Shih Jen Liu, Pele Chong, Hsin Wei Chen

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The role of interleukin (IL)-21 in influencing tumor growth or enhancing anti-tumor immunity is somewhat controversial. To further understand the potential regulatory effects of IL-21, we utilized an IL-21-secreting EG7 tumor model to demonstrate the direct effects of IL-21 on host tumor-infiltrating lymphocyte (TIL) profiles. Vector control EG7 cells (EG7-Vec) produced very low amounts of IL-21 and were highly tumorigenic. In contrast, IL-21-expressing EG7 cells, EG7-IL-21L and EG7-IL-21H, secreted relatively and extremely high levels of IL-21, respectively. Most importantly, both IL-21-expressing EG7 cells' control of tumor growth was not due to increased proliferative ability of tumor cells, but resulted from the induction of cytotoxic cellular responses in immunocompetent mice. To identify the effects of cancer immunoediting, tumor-infiltrating lymphocyte profiles were analyzed. NK cell populations appeared to be increased in EG7-IL-21H tumor sites at days 6-8 (progression stage), though this phenomenon did not persist at days 10-12 (regression stage). However, at both days 6-8 and 10-12, a higher frequency of CD8+ T cells was observed at the tumor site in EG7-IL-21H-inoculated mice than in EG7-Vec-inoculated mice. These findings suggest that NK cell-mediated tumor rejection may efficiently drive the development of tumor-specific cytotoxic T cell responses with the help of elevated IL-21 expression. These results also suggest the therapeutic potential of IL-21.

Original languageEnglish
Pages (from-to)491-496
Number of pages6
JournalImmunobiology
Volume216
Issue number4
DOIs
Publication statusPublished - 2011
Externally publishedYes

Fingerprint

Lymphocytes
Growth
Interleukins
Neoplasms
Tumor-Infiltrating Lymphocytes
Natural Killer Cells
interleukin-21
T-Lymphocytes
Immunity
Population

Keywords

  • IL-21
  • Regulatory T cell
  • Tumor-infiltrating lymphocytes

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Hematology

Cite this

Increased expression of IL-21 reduces tumor growth by modulating the status of tumor-infiltrated lymphocytes. / Hsieh, Chia Ling; Hsu, Shu Ching; Shen, Chia Rui; Chen, Mei Yu; Liu, Shih Jen; Chong, Pele; Chen, Hsin Wei.

In: Immunobiology, Vol. 216, No. 4, 2011, p. 491-496.

Research output: Contribution to journalArticle

Hsieh, Chia Ling ; Hsu, Shu Ching ; Shen, Chia Rui ; Chen, Mei Yu ; Liu, Shih Jen ; Chong, Pele ; Chen, Hsin Wei. / Increased expression of IL-21 reduces tumor growth by modulating the status of tumor-infiltrated lymphocytes. In: Immunobiology. 2011 ; Vol. 216, No. 4. pp. 491-496.
@article{161177507bb24d96a47c8bb3b66b707d,
title = "Increased expression of IL-21 reduces tumor growth by modulating the status of tumor-infiltrated lymphocytes",
abstract = "The role of interleukin (IL)-21 in influencing tumor growth or enhancing anti-tumor immunity is somewhat controversial. To further understand the potential regulatory effects of IL-21, we utilized an IL-21-secreting EG7 tumor model to demonstrate the direct effects of IL-21 on host tumor-infiltrating lymphocyte (TIL) profiles. Vector control EG7 cells (EG7-Vec) produced very low amounts of IL-21 and were highly tumorigenic. In contrast, IL-21-expressing EG7 cells, EG7-IL-21L and EG7-IL-21H, secreted relatively and extremely high levels of IL-21, respectively. Most importantly, both IL-21-expressing EG7 cells' control of tumor growth was not due to increased proliferative ability of tumor cells, but resulted from the induction of cytotoxic cellular responses in immunocompetent mice. To identify the effects of cancer immunoediting, tumor-infiltrating lymphocyte profiles were analyzed. NK cell populations appeared to be increased in EG7-IL-21H tumor sites at days 6-8 (progression stage), though this phenomenon did not persist at days 10-12 (regression stage). However, at both days 6-8 and 10-12, a higher frequency of CD8+ T cells was observed at the tumor site in EG7-IL-21H-inoculated mice than in EG7-Vec-inoculated mice. These findings suggest that NK cell-mediated tumor rejection may efficiently drive the development of tumor-specific cytotoxic T cell responses with the help of elevated IL-21 expression. These results also suggest the therapeutic potential of IL-21.",
keywords = "IL-21, Regulatory T cell, Tumor-infiltrating lymphocytes",
author = "Hsieh, {Chia Ling} and Hsu, {Shu Ching} and Shen, {Chia Rui} and Chen, {Mei Yu} and Liu, {Shih Jen} and Pele Chong and Chen, {Hsin Wei}",
year = "2011",
doi = "10.1016/j.imbio.2010.09.002",
language = "English",
volume = "216",
pages = "491--496",
journal = "Immunobiology",
issn = "0171-2985",
publisher = "Urban und Fischer Verlag GmbH und Co. KG",
number = "4",

}

TY - JOUR

T1 - Increased expression of IL-21 reduces tumor growth by modulating the status of tumor-infiltrated lymphocytes

AU - Hsieh, Chia Ling

AU - Hsu, Shu Ching

AU - Shen, Chia Rui

AU - Chen, Mei Yu

AU - Liu, Shih Jen

AU - Chong, Pele

AU - Chen, Hsin Wei

PY - 2011

Y1 - 2011

N2 - The role of interleukin (IL)-21 in influencing tumor growth or enhancing anti-tumor immunity is somewhat controversial. To further understand the potential regulatory effects of IL-21, we utilized an IL-21-secreting EG7 tumor model to demonstrate the direct effects of IL-21 on host tumor-infiltrating lymphocyte (TIL) profiles. Vector control EG7 cells (EG7-Vec) produced very low amounts of IL-21 and were highly tumorigenic. In contrast, IL-21-expressing EG7 cells, EG7-IL-21L and EG7-IL-21H, secreted relatively and extremely high levels of IL-21, respectively. Most importantly, both IL-21-expressing EG7 cells' control of tumor growth was not due to increased proliferative ability of tumor cells, but resulted from the induction of cytotoxic cellular responses in immunocompetent mice. To identify the effects of cancer immunoediting, tumor-infiltrating lymphocyte profiles were analyzed. NK cell populations appeared to be increased in EG7-IL-21H tumor sites at days 6-8 (progression stage), though this phenomenon did not persist at days 10-12 (regression stage). However, at both days 6-8 and 10-12, a higher frequency of CD8+ T cells was observed at the tumor site in EG7-IL-21H-inoculated mice than in EG7-Vec-inoculated mice. These findings suggest that NK cell-mediated tumor rejection may efficiently drive the development of tumor-specific cytotoxic T cell responses with the help of elevated IL-21 expression. These results also suggest the therapeutic potential of IL-21.

AB - The role of interleukin (IL)-21 in influencing tumor growth or enhancing anti-tumor immunity is somewhat controversial. To further understand the potential regulatory effects of IL-21, we utilized an IL-21-secreting EG7 tumor model to demonstrate the direct effects of IL-21 on host tumor-infiltrating lymphocyte (TIL) profiles. Vector control EG7 cells (EG7-Vec) produced very low amounts of IL-21 and were highly tumorigenic. In contrast, IL-21-expressing EG7 cells, EG7-IL-21L and EG7-IL-21H, secreted relatively and extremely high levels of IL-21, respectively. Most importantly, both IL-21-expressing EG7 cells' control of tumor growth was not due to increased proliferative ability of tumor cells, but resulted from the induction of cytotoxic cellular responses in immunocompetent mice. To identify the effects of cancer immunoediting, tumor-infiltrating lymphocyte profiles were analyzed. NK cell populations appeared to be increased in EG7-IL-21H tumor sites at days 6-8 (progression stage), though this phenomenon did not persist at days 10-12 (regression stage). However, at both days 6-8 and 10-12, a higher frequency of CD8+ T cells was observed at the tumor site in EG7-IL-21H-inoculated mice than in EG7-Vec-inoculated mice. These findings suggest that NK cell-mediated tumor rejection may efficiently drive the development of tumor-specific cytotoxic T cell responses with the help of elevated IL-21 expression. These results also suggest the therapeutic potential of IL-21.

KW - IL-21

KW - Regulatory T cell

KW - Tumor-infiltrating lymphocytes

UR - http://www.scopus.com/inward/record.url?scp=79952135193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952135193&partnerID=8YFLogxK

U2 - 10.1016/j.imbio.2010.09.002

DO - 10.1016/j.imbio.2010.09.002

M3 - Article

C2 - 20884078

AN - SCOPUS:79952135193

VL - 216

SP - 491

EP - 496

JO - Immunobiology

JF - Immunobiology

SN - 0171-2985

IS - 4

ER -